Definitive Healthcare Ownership

DH
 Stock
  

USD 12.00  0.63  5.54%   

Some institutional investors establish a significant position in stocks such as Definitive Healthcare in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Definitive Healthcare, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Continue to Investing Opportunities.
  
Definitive Healthcare retains a total of 105.08 Million outstanding shares. The majority of Definitive Healthcare Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Definitive Healthcare to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Definitive Healthcare. Please pay attention to any change in the institutional holdings of Definitive Healthcare Corp as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Definitive Stock Ownership Analysis

About 98.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.25. Some equities with similar Price to Book (P/B) outperform the market in the long run. Definitive Healthcare has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 0.16. The firm had not issued any dividends in recent years. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Definitive Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 676 people. To learn more about Definitive Healthcare Corp call Robert JD at 508 720 4224 or check out https://www.definitivehc.com.

Definitive Healthcare SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Definitive Healthcare prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Definitive Healthcare investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Definitive Healthcare specific information freely available to individual and institutional investors to make a timely investment decision.
4th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
26th of May 2022
Submission of Matters to a Vote of Security Holders
View
14th of February 2022
Unclassified Corporate Event
View

Definitive Healthcare Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Krantz Jason Ronald over three weeks ago via Macroaxis 
Purchase by Krantz Jason Ronald of 450000 shares of Definitive Healthcare
Maack Jonathan over three weeks ago via Macroaxis 
Acquisition by Maack Jonathan of 546303 shares of Definitive Healthcare subject to Rule 16b-3
Musslewhite Robert W over a month ago via Macroaxis 
Payment of 70658 shares by Musslewhite Robert W of Definitive Healthcare subject to Rule 16b-3
Chilukuri Sastry over a month ago via Macroaxis 
Acquisition by Chilukuri Sastry of 26588 shares of Definitive Healthcare subject to Rule 16b-3
Krantz Jason Ronald over two months ago via Macroaxis 
Payment of 10597 shares by Krantz Jason Ronald of Definitive Healthcare subject to Rule 16b-3
Sea Vii Management Llc over three months ago via Macroaxis 
Conversion by Sea Vii Management Llc of 1016000 shares of Definitive Healthcare
Larsen Jill over six months ago via Macroaxis 
Acquisition by Larsen Jill of 14545 shares of Definitive Healthcare subject to Rule 16b-3
Haywood Jeffrey Charles over six months ago via Macroaxis 
Sale by Haywood Jeffrey Charles of 18315 shares of Definitive Healthcare
Booth Richard Douglas over six months ago via Macroaxis 
Purchase by Booth Richard Douglas of 2374 shares of Definitive Healthcare
Krantz Jason Ronald over a year ago via Macroaxis 
Disposition of 688165 shares by Krantz Jason Ronald of Definitive Healthcare subject to Rule 16b-3
Winters Kathleen A over a year ago via Macroaxis 
Acquisition by Winters Kathleen A of 6737 shares of Definitive Healthcare subject to Rule 16b-3
Musslewhite Robert W over a year ago via Macroaxis 
Acquisition by Musslewhite Robert W of 650000 shares of Definitive Healthcare subject to Rule 16b-3

Be your own money manager

Our tools can tell you how much better you can do entering a position in Definitive Healthcare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module

Pair Trading with Definitive Healthcare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Definitive Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Definitive Healthcare will appreciate offsetting losses from the drop in the long position's value.

Moving against Definitive Healthcare

-0.52RYCEYRolls Royce Holdings Downward RallyPairCorr
The ability to find closely correlated positions to Definitive Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Definitive Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Definitive Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Definitive Healthcare Corp to buy it.
The correlation of Definitive Healthcare is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Definitive Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Definitive Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Definitive Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Investing Opportunities. Note that the Definitive Healthcare information on this page should be used as a complementary analysis to other Definitive Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Definitive Stock analysis

When running Definitive Healthcare price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is Definitive Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.3 B
Quarterly Revenue Growth YOY
0.33
Return On Assets
(0.0108) 
Return On Equity
(0.0317) 
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine Definitive Healthcare value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.